Pfizer Inc. buy Scotiabank
Start price
14.11.25
/
50%
€21.90
Target price
14.11.26
-
Performance (%)
1.00%
Price
16.01.26
€22.12
Summary
This prediction is currently active. The BUY prediction by Scotiabank shows slight gains of 1.00%. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 1.028% | 1.028% |
| iShares Core DAX® | 0.191% | 4.892% |
| iShares Nasdaq 100 | -0.614% | 2.901% |
| iShares Nikkei 225® | 0.599% | 7.404% |
| iShares S&P 500 | -0.036% | 3.489% |
Comments by Scotiabank for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (NYSE:PFE) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for PFE provided by MarketBeat